A promising medication , retatrutide, is sparking considerable buzz in the field of weight management . This novel therapy, a dual -action receptor agonist, appears to target both GLP-1 and GIP hormones, https://cecilyddzy464684.blogdigy.com/retatrutide-the-new-weight-loss-hope-66739396